Manufacturers’ views on outcome-based agreements

INTRODUCTION: Outcome-based agreements (OBAs) are occasionally deployed to relieve the burden of high drug prices on healthcare budgets. However, it is not clear when manufacturers are willing to collaborate in establishing such agreements. Therefore, we explored the feasibility of OBAs from the man...

Descripción completa

Detalles Bibliográficos
Autores principales: Barjestehvan Waalwijk van Doorn-Khosrovani, Sahar, Timmers, Lonneke, Pisters-van Roy, Anke, Gijzen, Joël, Blijlevens, Nicole M.A., Bloemendal, Haiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567951/
https://www.ncbi.nlm.nih.gov/pubmed/34745459
http://dx.doi.org/10.1080/20016689.2021.1993593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567951/
https://www.ncbi.nlm.nih.gov/pubmed/34745459
http://dx.doi.org/10.1080/20016689.2021.1993593

Ejemplares similares